Frontier AI Labs with Wil Waldon

Weekly Tech news roundup

Frontier AI Labs with Wil Waldon

Show Notes

Weekly Tech news roundup

More from Frontier AI Labs with Wil Waldon

Oct 22, 2026

Who controls AI when the computing moves onto your desk, the bills reach into the billions, and the biggest risks come from inside the company? Frontier Labs brings together three conversations about Meta's Muse Spark Open and local AI on Mac Studio, Anthropic's reported revenue growth and computing commitments, and the OpenAI recording-device case. We examine the tradeoffs between owning hardware and renting intelligence, the difference between growth and sustainable profits, and the tension between workplace security and employee privacy. These archive conversations come from source episodes created October 14–15, 2026, and reflect reporting available at that time. The OpenAI criminal case concerns allegations, not a finding of guilt; the defendant is presumed innocent unless proven guilty.

Oct 20, 2026

Who benefits when technology companies promise more ownership, convenience, and security? This hour-long Frontier Labs compilation connects six conversations: SpaceX’s proposed stock giveaway, why high earners can feel cash-poor, Apple’s home AI plans, Amazon Bee’s always-listening wearables, Anthropic’s approach to AI legislation, and the business behind an Elizabeth Holmes documentary. Across money, personal privacy, corporate influence, and entertainment, we examine how companies earn trust, shape behavior, and turn attention into revenue. Follow Frontier Labs for more conversations about technology, business, and the decisions shaping everyday life.

Oct 20, 2026

A24’s documentary "You Can See Everything," directed by Nathan Fielder and Lance Oppenheim, achieved a massive box office success by pulling in $15 million on only 855 screens during its opening weekend. Marketing professionals have praised the studio's strategic scarcity approach, which relied on an ambiguous trailer, strict secrecy regarding spoilers, and a limited initial theatrical release to build immense public anticipation. Despite being a nearly three-hour non-fiction feature about disgraced Theranos founder Elizabeth Holmes, the film resonated heavily with younger demographics and generated significant Oscar buzz. However, the rollout faced criticism from international cinephiles over staggered global release dates that created weeks of delay for audiences outside of North America. Ultimately, industry experts highlighted the project as a marketing masterclass that proved how minimal advertising and controlled availability can outperform traditional, high-budget distribution strategies.

Oct 19, 2026

SpaceX now wants Flight 15 to catch both Super Heavy and Starship, then send those same vehicles back to space on Flight 16. This video follows the full scenario from the double catch through inspection, pad preparation, and the decision that could produce the first reflight of a complete orbital rocket.

Oct 17, 2026

Eight U.S. states announced separate lawsuits against OpenAI on October 14, alleging misleading safety claims and failures to protect young users. This episode examines the different state claims, Iowa's requested restrictions, OpenAI's response, and what its published safeguards and evaluations do and don't establish. Allegations remain unproven.

See all episodes →